Deep learning empowered gadolinium-free contrast-enhanced abbreviated MRI for diagnosing hepatocellular carcinoma.
Journal:
JHEP reports : innovation in hepatology
Published Date:
Mar 12, 2025
Abstract
BACKGROUND & AIMS: By reducing some magnetic resonance imaging (MRI) sequences, abbreviated MRI (aMRI) has shown extensive promise for detecting hepatocellular carcinoma (HCC). We aim to develop deep learning (DL)-based gadolinium-free contrast-enhanced (CE) aMRI protocols (DL-aMRI) for detecting HCC.
Authors
Keywords
No keywords available for this article.